PCVX Vaxcyte, Inc.
Healthcare$50.11+5.94%ClosedMarket Cap: $7.24B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
2.20
P/S
0.00
EV/EBITDA
-7.07
DCF Value
$-0.57
FCF Yield
-11.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-32.5%
ROA
-28.3%
ROIC
-35.0%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-345.9M | $-320.6M | $— | — |
| Q4 null | $0.00 | Infinity% | $-274.3M | $-246.5M | $— | — |
| FY null | $0.00 | NaN% | $-923.7M | $-766.6M | $— | — |
| Q3 null | $0.00 | NaN% | $-242.4M | $-212.8M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-226.2M | $-166.6M | $— | — |
| Q1 null | $0.00 | NaN% | $-180.8M | $-140.7M | $— | — |
| Q4 null | $0.00 | NaN% | $-162.2M | $-137.1M | $— | — |
| FY null | $0.00 | NaN% | $-569.5M | $-463.9M | $— | — |
| Q3 null | $0.00 | NaN% | $-139.9M | $-103.1M | $— | — |
| Q2 null | $0.00 | NaN% | $-153.0M | $-128.7M | $— | — |
| Q1 null | $0.00 | NaN% | $-114.5M | $-95.0M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-196.7M | $-180.8M | $-1.73 | — |